Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 (Antiplatelet therapy for reduction of myocardial damage during angioplasty) study - Patti, G; Colonna, G; Pasceri, V (Circulation, 2005)
et al.